Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in SLE Inflammatory Polyarthritis
NCT02429934Phase 2Terminated
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2015
- Primary completion
- Sep 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of abatacept in systemic lupus erythematosus (SLE), sponsored by University of California, Los Angeles. Started Oct 2015; status: terminated.
02
Drugs
abatacept
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT02429934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429934.